Loading...

Biomarkers in Cancer Screening and Early Detection

ISBN: 978-1-118-46882-1

June 2017

Wiley-Blackwell

320 pages

Description

Prepared by world leaders on this topic, Biomarkers in Cancer Screening and Early Detection offers a comprehensive, state-of-the-art perspective on the various research and clinical aspects of cancer biomarkers, from their discovery and development to their validation, clinical utility, and use in developing personalized cancer treatment.

  • Offers a comprehensive, state-of-the-art perspective on the various research and clinical aspects of cancer biomarkers
  • Provides immediately actionable information – and hopefully also inspiration – to move discovery and clinical application forward
  • Offers vital knowledge to help develop personalized cancer treatment for individual patients with specific cancers
About the Author

Edited by
Sudhir Srivastava, Ph.D., MPH
Senior Scientific Officer, Chief, Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Translational Oncology Series
Series Editors
ROBERT C. BAST, MD,
Vice President for Translational Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

MAURIE MARKMAN, MD, Senior Vice President for Clinical Affairs, Cancer Treatment Centers of America, Clinical Professor of Medicine, Drexel University College of Medicine, Philadelphia, PA, USA

ERNEST HAWK, MD, MPH, Vice President, Division of OVP, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA